🇺🇸 FDA
Patent

US 8785499

Targeting NAD biosynthesis in bacterial pathogens

granted A61PA61P31/04

Quick answer

US patent 8785499 (Targeting NAD biosynthesis in bacterial pathogens) held by The Board of Regents of the University of Texas System expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P31/04